Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|18|25|3615-3623
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.18, Iss.25, 2012-07, pp. : 3615-3623
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Idarucizumab: What Should We Know?
Current Drug Targets, Vol. 19, Iss. 1, 2018-01 ,pp. :
Access to resources
Recommend
Neuropsychiatric Adverse Effects of Mefloquine: What Do We Know and What Should We Do?
By Nosten F.
CNS Drugs, Vol. 11, Iss. 1, 1999-01 ,pp. :
Child and Adolescent Psychopharmacology News, Vol. 9, Iss. 4, 2004-06 ,pp. :
Semantic Dementia: A Mini-Review
Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 1, 2017-12 ,pp. :